Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and equivalents	$ 2,211	$ 2,213
Accounts and other current receivables, net	1,830	1,731
Inventories	1,682	1,604
Prepaid expenses and other	951	855
Investment in Baxalta common stock	1,232	5,148
Current assets held for disposition	111	245
Total current assets	8,017	11,796
Property, plant and equipment, net	4,403	4,386
Other assets
Goodwill	2,727	2,687
Other intangible assets, net	1,359	1,349
Other	844	744
Total other assets	4,930	4,780
Total assets	17,350	20,962
Current liabilities
Short-term debt	817	1,775
Current maturities of long-term debt and lease obligations	472	810
Accounts payable and accrued liabilities	2,387	2,666
Current income taxes payable	137	453
Current liabilities held for disposition	10	46
Total current liabilities	3,823	5,750
Long-term debt and lease obligations	2,068	3,922
Other long-term liabilities	2,439	2,425
Equity
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2016 and 2015	683	683
Common stock in treasury, at cost, 132,271,988 shares in 2016 and 135,839,938 shares in 2015	(7,434)	(7,646)
Additional contributed capital	5,882	5,902
Retained earnings	12,923	9,683
Accumulated other comprehensive (loss) income	(3,035)	224
Total Baxter shareholders' equity	9,019	8,846
Noncontrolling interests	1	19
Total equity	9,020	8,865
Total liabilities and equity	$ 17,350	$ 20,962